Klinkmann, Gerd https://orcid.org/0000-0002-8922-8700
Reis, Thiago
Ronco, Claudio
,
Whaley-Connell, Adam
Tolwani, Ahsita
Zarbock, Alexander
Lorenzin, Anna
Fuhrman, Dana
Soranno, Danielle E.
See, Emily
Guimaraes, Gabriela
Bottari, Gabriella
Gomez, Hernando
Husain-Syed, Faeq
Baldwin, Ian
Milet, Igor
Neyra, Javier A.
Teixeira, Joao
Prowle, John
Kashani, Kianoush
Marcello, Matteo
Joannidis, Michael
Ramírez-Guerrero, Gonzalo
De Rosa, Silvia
Premužić, Vedran
Funding for this research was provided by:
Universitätsmedizin Rostock
Article History
Received: 15 December 2025
Accepted: 23 December 2025
First Online: 20 January 2026
Declarations
:
: Gerd Klinkmann has received funding for lectures for Artcline GmbH and CytoSorbents Europe GmbH and has received research grants from the German Society of Anaesthesiology and Intensive Care; Thiago Reis has received funding for lectures and has been a consultant or advisory board member for Alexion, AstraZeneca, B. Braun, Baxter, bioMérieux, Boehringer Ingelheim, Contatti (CytoSorbents), Eurofarma, George Clinical, Jafron, Lifepharma, Medcorp, Nipro, and Nova Biomedical. Claudio Ronco has been on advisory boards or speaker’s bureau for AstraZeneca, Aferetica, Asahi, B. Braun, Baxter, bioMérieux, CytoSorbents, GE, Medica, Medtronic, and Jafron.
: Not applicable.
: All authors have read the correspondence and agree to submit and publish it.